Influenza

Influenza — scientific infographic poster
Influenza virus replication

Table of Contents

  1. What is Influenza?
  2. Flu, Cold or COVID? Telling Them Apart
  3. Symptoms and How They Progress
  4. Who Is at Higher Risk
  5. Diagnosis and Testing
  6. Treatment: What the Antivirals Do and Do Not Do
  7. Caring for Yourself at Home
  8. Prevention and Vaccination
  9. Supplements: Honest Evidence Tiers
  10. Red Flags: When to Get Help Immediately
  11. Complications
  12. References & Research
  13. Research Papers
  14. Connections
  15. Featured Videos

What is Influenza?

Influenza — "the flu" — is an infection of the nose, throat and lungs caused by influenza viruses. It is a genuinely different illness from a common cold, and treating the two as interchangeable is the source of most of the confusion around it.

Why the flu comes back every year when measles does not

Have chickenpox once and you are generally done. Influenza comes back annually, and the reason is written into the virus's surface.

Two proteins stud that surface: haemagglutinin (H), the grappling hook the virus uses to attach to your airway cells, and neuraminidase (N), the scissors it uses to cut newly made copies free. That is where names like H1N1 and H3N2 come from. Your immune system learns to recognise those two shapes, and antibodies against them are what protect you.

The virus stores its genetic code as RNA and copies it with an enzyme that makes frequent mistakes and does not proofread. Every generation therefore carries small errors, and any error that changes the shape of H or N slightly makes last year's antibodies fit a little less well. Over a season or two the accumulated changes are enough to get past your defences. This gradual drift is why the vaccine is reformulated every year — it is not that the vaccine "wears off", it is that the target moved.

There is a rarer and more dangerous version. The influenza A genome comes in eight separate segments, so if two different influenza viruses infect the same cell they can swap whole segments like shuffling two decks together. An entirely new H can appear in a virus that spreads easily between people, and because nobody's immune system has seen it, it can spread worldwide. That reassortment — antigenic shift — is what produces pandemics, and it is why influenza in birds and pigs is watched so closely.

The types, briefly

The scale is easy to underestimate. A modelling study covering countries representing 57% of the world's population estimated 291,000 to 646,000 seasonal influenza-associated respiratory deaths each year, with by far the highest rates in people aged 75 and over (51.3 to 99.4 per 100,000) — higher than previous estimates had suggested [1].

Back to Table of Contents

Flu, Cold or COVID? Telling Them Apart

People routinely say "flu" for any bad cold, which matters because the treatment window for real influenza is measured in hours.

The most useful single discriminator is how it started. A cold creeps up: a scratchy throat one day, a stuffy nose the next, gradually feeling worse over two or three days. Influenza arrives like a wall. People can often name the hour — "I was fine at two o'clock and by five I was in bed shivering". That abrupt onset, with fever and whole-body aches, in a season when flu is circulating, is the picture.

COVID-19 overlaps heavily with influenza and cannot be told apart reliably on symptoms alone. Loss of taste or smell points more toward COVID but is far from universal, and onset can be gradual with either. Since the treatments differ, and both have antiviral options that work best when started early, a combined test is often the practical answer.

Two other things get called flu and are not: "stomach flu" — vomiting and diarrhoea — is gastroenteritis, usually norovirus or rotavirus, and has nothing to do with influenza; the flu vaccine does not prevent it. And a rapid onset of fever with a very sore throat and no cough may be strep throat, which needs antibiotics.

Back to Table of Contents

Symptoms and How They Progress

Typical symptoms include:

The usual timeline

The pattern that should worry you is getting better and then getting worse again. A second fever after several days of improvement, or new breathlessness or chest pain, suggests a bacterial pneumonia developing on top of the flu, and needs medical assessment.

How presentation varies

Back to Table of Contents

Who Is at Higher Risk

This list matters practically: it determines who should be tested and treated quickly rather than told to rest at home.

Back to Table of Contents

Diagnosis and Testing

In the middle of a busy flu season, a doctor may reasonably diagnose influenza on the story alone in a healthy adult, because testing will not change what happens. Testing matters when the answer would change treatment or precautions — in people at higher risk, in hospital, and in care homes.

The IDSA guideline is explicit that in high-risk patients, antiviral treatment should be started on clinical suspicion without waiting for a test result, because the benefit depends on starting early [2]. If you are in a risk group, the useful thing to say on the phone is not "I think I have flu" but "I am in a high-risk group, this started suddenly today, and I would like to be assessed for antiviral treatment."

Back to Table of Contents

Treatment: What the Antivirals Do and Do Not Do

This is an area where the evidence is genuinely contested, and it is worth having the real numbers rather than either the marketing or the backlash.

Oseltamivir (Tamiflu) — two credible readings of the same drug

A meta-analysis of nine trials in 4,328 patients found that in those with confirmed influenza, oseltamivir shortened time to symptom relief by about 21% — a median of 97.5 hours versus 122.7, a difference of about 25 hours. It also reported fewer lower respiratory complications requiring antibiotics (4.9% versus 8.7%) and fewer hospital admissions (0.6% versus 1.7%). Against that, nausea rose from 6.2% to 9.9% and vomiting from 3.3% to 8.0% [3]. That analysis was funded by a group supported by the manufacturer, which is relevant context rather than a disqualification.

A Cochrane review that obtained the full clinical study reports — including unpublished trials — reached a more sceptical conclusion. It found oseltamivir shortened symptoms in adults by 16.8 hours (from about 7 days to 6.3), but found no significant effect on hospitalisation and no significant reduction in serious complications, while noting a high risk of bias across the trial programme [4].

The honest synthesis: oseltamivir reliably shortens symptoms by roughly a day. Whether it prevents complications and hospital admission in otherwise healthy people is genuinely disputed, and the strongest claims rest on the weaker evidence. What both sides broadly accept is that treatment is most worthwhile in people at high risk of complications and in those sick enough to be hospitalised, and that starting within 48 hours of symptom onset is what determines whether it does anything at all. For a healthy 30-year-old presenting on day four, it is close to pointless.

Baloxavir (Xofluza) — one dose, and a resistance caveat

Baloxavir works on a different viral enzyme and is taken as a single dose. In its phase 3 trial, median time to symptom relief was 53.7 hours versus 80.2 hours on placebo, and it reduced viral load faster than either placebo or oseltamivir — though time to symptom relief was similar to oseltamivir. Adverse events were no more frequent than placebo. The important caveat is resistance: virus variants with reduced susceptibility emerged in 9.7% of baloxavir recipients in the phase 3 trial [5].

What antivirals are not

They are not antibiotics, and antibiotics do nothing for influenza itself — they are for a bacterial infection developing on top of it. Antivirals also do not substitute for vaccination, and their modest benefit is a poor trade against skipping a vaccine.

Aspirin must not be given to children or teenagers with influenza or chickenpox because of the risk of Reye's syndrome, a rare but often fatal brain and liver injury. Use paracetamol/acetaminophen or ibuprofen instead.

Back to Table of Contents

Caring for Yourself at Home

For most healthy adults influenza is managed at home, and the basics genuinely help.

Protecting other people. You are typically infectious from about a day before symptoms until roughly five to seven days after they start, and longer in children and those with weakened immunity. Stay home until you have been fever-free for 24 hours without fever-reducing medicine. Cover coughs, wash hands, and keep away from anyone in a high-risk group — the newborn, the grandparent on chemotherapy.

Back to Table of Contents

Prevention and Vaccination

The vaccine, and the honest version of its effectiveness

Annual vaccination is the single most effective preventive measure. It is also routinely oversold and then over-dismissed, so here is the shape of it.

Effectiveness varies year to year, largely depending on how well the strains chosen months in advance match what actually circulates. In a good match it prevents a substantial share of infections; in a poor year it prevents fewer. Two things are consistently true even in mismatched years: it reduces the severity of illness in people who catch flu anyway, and it reduces hospitalisation and death, which is the outcome that matters most for those at risk.

"I got the flu from the flu shot" is not possible with the injected vaccines — they contain no live virus. A sore arm, mild aches and feeling off for a day are the immune system responding, not an infection. It also takes about two weeks to build protection, so flu caught in that window is often blamed on the vaccine.

Practical points: vaccination is recommended annually for essentially everyone from six months of age, with particular emphasis on the high-risk groups above. Higher-dose and adjuvanted formulations exist for adults 65 and over, because immune response weakens with age. Vaccination in pregnancy protects both the mother and, through transferred antibodies, the infant in its first months — the period when the baby is too young to be vaccinated and most vulnerable. An egg allergy is no longer a barrier for standard vaccines.

One under-appreciated benefit: influenza vaccination is associated with fewer cardiovascular events in people with heart disease. If you have had a heart attack or have heart failure, the flu vaccine is part of cardiac care, not just respiratory care.

Everything else

Hand-washing, not touching your face, ventilating indoor spaces, and staying home when ill all reduce transmission. Masks reduce it in crowded indoor settings. For household contacts of a confirmed case who are at high risk, antiviral prophylaxis is sometimes used [2].

Back to Table of Contents

Supplements: Honest Evidence Tiers

Vitamin D — modest, real, and concentrated in the deficient. A meta-analysis of individual participant data from 25 randomized trials covering 11,321 people found vitamin D supplementation reduced acute respiratory tract infection overall (adjusted odds ratio 0.88). The effect was seen with daily or weekly dosing (OR 0.81) but not with large intermittent bolus doses (OR 0.97), and it was much stronger in people who started very deficient, below 25 nmol/L (OR 0.30), than in those above that (OR 0.75) [6]. Practical translation: correcting a genuine deficiency with regular modest dosing is worthwhile; occasional megadoses are not; and this covers respiratory infections broadly rather than influenza specifically. See Vitamin D3.

Zinc — lozenges have reasonable evidence for shortening the common cold when started within 24 hours. The evidence in influenza specifically is thin, high doses cause nausea, and intranasal zinc has caused permanent loss of smell and should be avoided. See Zinc.

Vitamin C — regular supplementation slightly shortens cold duration in most people; starting it once you are already ill does little. It is not an influenza treatment. See Vitamin C.

Elderberry — small trials suggest shortened symptom duration, but they are small, several are industry-linked, and a larger trial was less positive. Reasonable to try, not a substitute for antivirals in a high-risk person. See Elderberry.

Echinacea — trials are numerous and inconsistent, with product preparations varying so much that results are hard to pool. The honest tier is unproven.

None of these is a reason to skip vaccination or to delay antivirals if you are in a high-risk group.

Back to Table of Contents

Red Flags: When to Get Help Immediately

Seek emergency care for an adult with:

In children, seek emergency care for: fast or laboured breathing, ribs pulling in with each breath, blue lips, not drinking or no wet nappy for many hours, no tears when crying, unusual sleepiness or floppiness, a rash that does not fade under pressure, fever in an infant under three months, or a seizure.

Contact a doctor promptly, rather than waiting, if you are in any of the high-risk groups above — the antiviral window is 48 hours, and it closes quietly.

Back to Table of Contents

Complications

The comprehensive clinical overview of the disease, its virology, epidemiology and management is set out in the Nature Reviews Disease Primers review of influenza [7].

Back to Table of Contents


References & Research

Historical Background

Influenza has caused devastating pandemics throughout history, most notably the 1918 Spanish flu pandemic that killed an estimated 50-100 million people worldwide. The influenza virus was first isolated in 1933 by Wilson Smith, Christopher Andrewes, and Patrick Laidlaw at the National Institute for Medical Research in London, enabling the subsequent development of antiviral therapies.

Key Research Papers

This list was rebuilt after an audit found that seven of the eight DOI links previously shown here resolved to an unrelated paper or to nothing at all. Every citation below was verified live against its own PubMed record — authors, journal, year and title all checked against the source.

  1. Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285-1300. PMID 29248255. doi:10.1016/S0140-6736(17)33293-2
  2. Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis. 2019;68(6):e1-e47. PMID 30566567. doi:10.1093/cid/ciy866
  3. Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729-1737. PMID 25640810. doi:10.1016/S0140-6736(14)62449-1
  4. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database Syst Rev. 2014;2014(4):CD008965. PMID 24718923. doi:10.1002/14651858.CD008965.pub4
  5. Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med. 2018;379(10):913-923. PMID 30184455. doi:10.1056/NEJMoa1716197
  6. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. PMID 28202713. doi:10.1136/bmj.i6583
  7. Krammer F, Smith GJD, Fouchier RAM, et al. Influenza. Nat Rev Dis Primers. 2018;4(1):3. PMID 29955068. doi:10.1038/s41572-018-0002-y

Back to Table of Contents


Research Papers

The following PubMed topic searches surface the current peer-reviewed literature on Influenza. Each link opens a live PubMed query; results update as new papers are indexed.

  1. PubMed search: influenza virus
  2. PubMed search: seasonal influenza vaccine
  3. PubMed search: influenza antiviral oseltamivir
  4. PubMed search: baloxavir marboxil influenza
  5. PubMed search: influenza pandemic
  6. PubMed search: influenza pathogenesis
  7. PubMed search: influenza complications pneumonia
  8. PubMed search: influenza hemagglutinin neuraminidase
  9. PubMed search: universal influenza vaccine
  10. PubMed search: influenza elderly mortality
  11. PubMed search: influenza H1N1 H3N2
  12. PubMed search: influenza A virus

Back to Table of Contents


Connections

Back to Table of Contents